LMR Partners’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

LMR Partners’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105,100	Closed	-$1.08M	–	1251
2023 Q1	$1.08M	Hold	105,100	–	–	0.02%	562
2022 Q4	$1.06M	Hold	105,100	–	–	0.02%	670
2022 Q3	$1.03M	Buy	+105,100	New	+$1.03M	0.02%	690

LMR Partners's ORIA Position: Q2 2023 in Review

LMR Partners sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 105,100 shares — an estimated $1.08M sold.

LMR Partners first reported a position in ORIA in Q3 2022 and held it in 3 quarters. The position peaked at $1.08M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

LMR Partners reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
LMR Partners sold 105,100 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.08M.
LMR Partners first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 3 quarters.
LMR Partners's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.08M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.